Lombard Medical, Inc.
EVARFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2795
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Lombard Medical, Inc.（EVARF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EVARF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2016-12 | 2015-12 |
|---|---|---|
| Revenue | ||
| Revenue | $12.17M | $15.11M |
| Cost of Revenue | $11.21M | $8.56M |
| Gross Profit | $0.95M | $6.56M |
| Gross Margin %(computed) | 7.85% | 43.38% |
| Operating Expenses | ||
| R&D Expenses | $7.48M | $11.02M |
| G&A Expenses | $0.00M | $0.00M |
| Total Operating Expenses | $30.29M | $46.02M |
| Operating Income | ($29.34M) | ($39.47M) |
| Operating Margin %(computed) | -241.06% | -261.13% |
| Interest Income | $0.09M | $0.13M |
| Interest Expense | $2.31M | $0.86M |
| Income Before Tax | ($32.52M) | ($40.02M) |
| Income Tax Expense | ($1.48M) | ($2.21M) |
| Net Income | ($31.04M) | ($37.80M) |
| Net Margin %(computed) | -255.03% | -250.13% |
| Per Share & EBITDA | ||
| EPS (Basic) | $-1.54 | $-2.13 |
| Wtd Avg Shares | 20.17M | 17.76M |
| EBITDA | ($28.07M) | ($37.36M) |
| EBITDA Margin %(computed) | -230.65% | -247.19% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Lombard Medical, Inc.
关于Lombard Medical, Inc.（EVARF）损益表
Lombard Medical, Inc.（EVARF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2016财年，EVARF实现营收$0.01B，毛利润$0.00B（毛利率7.85%），净利润($0.03B)（净利率-255.03%）。
常见问题
EVARF · 4 问Lombard Medical, Inc.（EVARF）2016财年营收为$0.01B，同比down19.5%。
EVARF revenueEVARF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09